Efficacy of FLT-PET assesment in treating head and neck cancer with chemoradiation

Efficacy of FLT-PET assesment in treating head and neck cancer with chemoradiation - FLT-PET for head and neck cancer treated with CRT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006202

Enrollment

Registered

2011-09-01

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

FLT-PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with untreated oropharyngeal, hypopharyngeal or laryngeal squamous cell carcinoma 2. Stage 3 or more 3. Patients with a primary lesion of 2cm or more in diameter

Exclusion criteria

Exclusion criteria: 1. Poor general condition 2. Cannot keep supine position for 60 minutes 3. Pregnant or possibility of pregnancy 4. Severe claustrophobia 5. Regarded as unsuitable by responsible investigators

Design outcomes

Primary

Measure	Time frame
TO investigate that the change of FLT uptake between pre-treatment and after 10-20Gy radiation correlates with the response of chemoradiation for head and neck cancer	—

Countries

Japan

Contacts

Public ContactMasahiro Kikuchi

Kobe City Medical Center General Hospital Otolaryngology and Hed and Neck Surgery

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026